Skip to main content
Clinical Trials/NCT04141683
NCT04141683
Unknown
Not Applicable

Prognostic Implication of Right Ventricular Contractile Reserve in Patients With Functional Tricuspid Regurgitation

Heart Center Leipzig - University Hospital1 site in 1 country108 target enrollmentJune 10, 2019

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Functional Tricuspid Regurgitation
Sponsor
Heart Center Leipzig - University Hospital
Enrollment
108
Locations
1
Primary Endpoint
Death or heart failure hospitalization
Last Updated
4 years ago

Overview

Brief Summary

Aim of the study is to investigate the prognostic value of right ventricular contractile reserve in patients with functional tricuspid regurgitation undergoing tricuspid valve repair or replacement.

Detailed Description

Chronic volume overload in patients with severe tricuspid regurgitation (TR) leads to right ventricular (RV) dilatation, fibrosis and eventually failure. RV dysfunction is an important determinant of mortality in patients undergoing tricuspid valve surgery. Aim of the current study is to investigate the prognostic utility of right ventricular contractile reserve in patients with severe TR undergoing surgical or interventional tricuspid valve repair or tricuspid valve replacement. RV contractile reserve will be assessed using semi-supine bicycle stress echocardiography. Echocardiographic parameters are prone to altered loading conditions, such as volume overload. Load independent RV contractility can only be measured using invasive pressure-volume-loop (PVL) analysis. Therefore RV PVL analysis will be done using conductance catheter in a subset of patients who undergo right heart catheterization for clinical evaluation of pulmonary hypertension. Aim of this sub study is the validation of non-invasively derived RV contractile reserve with load independent markers of intrinsic RV contractility.

Registry
clinicaltrials.gov
Start Date
June 10, 2019
End Date
December 2022
Last Updated
4 years ago
Study Type
Observational
Sex
All

Investigators

Sponsor
Heart Center Leipzig - University Hospital
Responsible Party
Principal Investigator
Principal Investigator

Philipp Lurz

Clinical Investigator, Professor, Managing Senior Physician

Heart Center Leipzig - University Hospital

Eligibility Criteria

Inclusion Criteria

  • Severe functional tricuspid regurgitation.
  • Planned surgical or interventional tricuspid valve repair or replacement.
  • Able to cycle on a semisupine tilting exercise table.
  • Informed consent.

Exclusion Criteria

  • Coronary artery disease with significant ischemia.
  • Unstable Angina.
  • Myocardial infarction \<4 month prior to inclusion.
  • Concomitant valvular heart disease (aortic, mitral or pulmonary valve) \> mild-moderate.
  • Constrictive pericarditis.
  • Malignant disease with a life expectancy \< 12 months.
  • Pregnancy.
  • Insufficient image quality on echocardiography.

Outcomes

Primary Outcomes

Death or heart failure hospitalization

Time Frame: 6-12 month

Death or heart failure hospitalization according to right ventricular contractile reserve.

Secondary Outcomes

  • Intrinsic RV contractility(Baseline)
  • Cardiovascular Death(6-12 month)
  • Heart Failure Hospitalization(6-12 month)
  • Death(6-12 month)

Study Sites (1)

Loading locations...

Similar Trials